BABA vs GEF

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

GEF presents a conflicting profile characterized by a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health, despite trading below its intrinsic value of $71.39. While the PEG ratio (0.77) and Forward P/E (14.24) suggest potential value, the company has missed earnings estimates in four consecutive quarters with a significant average surprise of -47.31%. The high dividend payout ratio of 89.26% combined with bearish insider activity and negative revenue growth creates a precarious environment for investors. Overall, the stock is a value trap candidate unless operational efficiency improves.